Key terms
About COO
The Cooper Cos, Inc. operates as a medical device company. It operates through the Cooper Vision and Cooper Surgical segments. The Cooper Vision segment develops, manufactures, and markets products for contact lens wearers, which solves vision challenges such as astigmatism, presbyopia, myopia, ocular dryness, and eye fatigues. The Cooper Surgical segment focuses on the provision of advancement for the health of women, babies, and families through women's health and fertility products and services. The company was founded in 1958 and is headquartered in San Ramon, CA.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest COO news
Yesterday
8:14am ET
Cooper Companies (NASDAQ:COO): Analysts Are Bullish on this MedTech S&P 500 Stock
Apr 03
5:51am ET
Cooper Companies price target raised to $116 from $108 at Citi
Mar 26
4:45am ET
Buy Rating Affirmed for Cooper Companies, Inc. on Optimistic FY2024 Outlook and Strategic Market Positioning
Mar 19
4:43am ET
Cooper Companies upgraded to Buy from Neutral at Redburn Atlantic
Mar 13
9:47am ET
Tesla downgraded, Southwest upgraded: Wall Street’s top analyst calls
Mar 13
5:01am ET
Analysts’ Top Healthcare Picks: Cooper Co (COO), Regeneron (REGN)
Mar 13
4:54am ET
Cooper Companies upgraded to Overweight from Neutral at JPMorgan
Mar 03
7:16am ET
J.P. Morgan Remains a Hold on Cooper Co (COO)
Mar 01
9:55am ET
Early notable gainers among liquid option names on March 1st
Mar 01
9:16am ET
Cooper Companies price target raised to $114 from $105 at BofA
Mar 01
9:03am ET
Cooper Companies price target raised to $110 from $105 at Stifel
Mar 01
8:47am ET
Cooper Companies price target raised to $115 from $110 at Piper Sandler
Mar 01
7:47am ET
Piper Sandler Sticks to Its Buy Rating for Cooper Co (COO)
Mar 01
7:33am ET
Cooper Companies price target raised to $115 from $102.50 at Mizuho
Mar 01
7:02am ET
Strong Q1 Performance and Positive Full-Year Outlook Justify Buy Rating for Cooper Co
Mar 01
6:51am ET
Analysts Conflicted on These Healthcare Names: Paragon 28 (FNA) and Cooper Co (COO)
Mar 01
6:46am ET
Cooper Companies price target raised to $116 from $108 at Baird
Mar 01
6:40am ET
Wall Street Analysts Are Bullish on Top Healthcare Picks
Mar 01
6:14am ET
Cooper Companies price target raised to $108 from $105 at Citi
Mar 01
5:50am ET
Analysts’ Opinions Are Mixed on These Healthcare Stocks: BioLife Solutions (BLFS), Cooper Co (COO) and PTC Therapeutics (PTCT)
Mar 01
5:38am ET
COO Earnings: CooperCompanies Jumps on Impressive Q1 Growth
Feb 29
4:29pm ET
Cooper Companies sees FY24 EPS $3.50-$3.58, consensus $3.46
Feb 29
4:27pm ET
Cooper Companies reports Q1 adjusted EPS 85c, consensus 78c
Feb 29
1:54pm ET
Notable companies reporting after market close
Feb 29
8:20am ET
Analysts Offer Insights on Healthcare Companies: Merit Medical Systems (MMSI), Jazz Pharmaceuticals (JAZZ) and Cooper Co (COO)
Feb 26
6:25am ET
Buy Rating Affirmed for The Cooper Companies, Inc. on Robust Q1 Outlook and Strong Market Position
Feb 26
1:09am ET
SPY ETF Update, 2/26/2024
Feb 21
8:00am ET
Analysts Conflicted on These Healthcare Names: Cooper Co (COO), Medtronic (MDT) and Globus Medical (GMED)
Feb 16
5:24pm ET
Cooper Co Announces Stock Split and Shareholder Adjustments
Feb 15
4:47pm ET
CooperCompanies to effect four-for-one stock split on February 16
Feb 06
9:55am ET
Tesla downgraded, UPS upgraded: Wall Street’s top analyst calls
No recent press releases are available for COO
COO Financials
Key terms
Ad Feedback
COO Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
COO Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range
